How do you prepare amiodarone (antiarrhythmic medication) for intravenous (IV) infusion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Amiodarone Preparation for Intravenous Infusion

Prepare amiodarone by diluting it in dextrose 5% in water (D5W) using glass or polyolefin bottles, and deliver it through a volumetric infusion pump with an in-line filter, preferably via a dedicated central venous catheter. 1

Critical Preparation Requirements

Diluent and Container Selection

  • Use only D5W (dextrose 5% in water) as the diluent for all amiodarone infusions 1
  • Use glass or polyolefin bottles exclusively for infusions exceeding 2 hours 1
  • Never use evacuated glass containers for admixing, as incompatibility with buffer in the container may cause precipitation 1
  • Do not use plastic containers in series connections, as this could result in air embolism 1

Concentration Guidelines

  • For infusions longer than 1 hour, do not exceed 2 mg/mL concentration unless using a central venous catheter 1
  • Concentrations greater than 3 mg/mL are associated with high incidence of peripheral vein phlebitis 1
  • Concentrations of 2.5 mg/mL or less are less irritating to peripheral veins 1
  • Acceptable concentration range is 1-6 mg/mL when using a central venous catheter 1

Standard Dosing Preparation

Loading Dose (First 24 Hours)

  • Rapid loading bolus: Mix 150 mg in 100 mL D5W for infusion over 10 minutes 2, 3, 1
  • Early maintenance: Prepare 360 mg (1 mg/min × 6 hours) in appropriate volume of D5W 2, 3, 1
  • Late maintenance: Prepare 540 mg (0.5 mg/min × 18 hours) in appropriate volume of D5W 2, 3, 1
  • Total first 24-hour dose should be approximately 1000 mg 1

Breakthrough Dose Preparation

  • Mix 150 mg in 100 mL D5W for supplemental infusions during breakthrough ventricular fibrillation or hemodynamically unstable ventricular tachycardia 1
  • Infuse over 10 minutes to minimize hypotension risk 1

Equipment and Administration Setup

Required Equipment

  • Use a volumetric infusion pump (mandatory—drop counter sets can underdose by up to 30% due to altered surface properties) 1
  • Use an in-line filter during all administrations 1
  • Administer through a central venous catheter whenever possible, dedicated to amiodarone 1

Tubing Considerations

  • PVC tubing is acceptable (all clinical experience has been with PVC tubing) 1
  • Be aware that amiodarone leaches plasticizers (DEHP) from PVC tubing, though this reflects standard clinical practice 1
  • The degree of leaching increases with higher concentrations and lower flow rates 1

Critical Safety Precautions

Preparation Warnings

  • Never exceed initial infusion rate of 30 mg/min 1
  • Loading infusions at much higher concentrations and faster rates than recommended have resulted in hepatocellular necrosis, acute renal failure, and death 1
  • Mean daily doses above 2100 mg are associated with increased risk of hypotension 1

Pre-Administration Checks

  • Inspect solution for particulate matter and discoloration before administration—solution should be clear 1
  • Amiodarone does not need protection from light during administration 1

Drug Incompatibilities

Y-Site Incompatibilities

  • Amiodarone in D5W forms precipitates with certain drugs and requires separate IV lines if coadministration is necessary 1
  • Check specific Y-site compatibility before mixing with other medications 1

Common Pitfalls to Avoid

  • Never use drop counter infusion sets—they will underdose by up to 30% 1
  • Never use concentrations >2 mg/mL for peripheral IV infusions lasting >1 hour (high phlebitis risk) 1
  • Never prepare in evacuated glass containers (precipitation risk) 1
  • Never use diluents other than D5W (incompatibility) 1
  • Never infuse faster than 30 mg/min initially (risk of hepatocellular necrosis and acute renal failure) 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Amiodarone Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.